ALKERMES | ALKS - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 521.8B 77.2B 2026-10
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Biogen USD 35.56B 2.19B 2026-10
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 124.51B 2.96B 2026-10
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.31T 216.84B 2026-10
Gilead Sciences USD 206.51B 21.7B 2026-10
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 607B 46.61B 2026-10
Malin Corporation EUR 133.52M 29.05M 2026-08
Merck USD 370.6B 12.1B 2026-10
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Otsuka Holdings JPY 6.45T 586.17B 2026-10
Ovoca Bio EUR 1.17M 18.38K 2025-12
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 100.79B 35.42B 2026-10
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06